These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4923064)

  • 21. Conditional mutator gene in Escherichia coli: isolation, mapping, and effector studies.
    Degnen GE; Cox EC
    J Bacteriol; 1974 Feb; 117(2):477-87. PubMed ID: 4590472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nature of the penetration barrier in Escherichia coli K-12: effect of macromolecular inhibition of penetrability in strains containing the envA gene.
    Normark S; Westling B
    J Bacteriol; 1971 Oct; 108(1):45-50. PubMed ID: 4941566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro selection of Escherichia coli mutants with decreased susceptibility to norfloxacin.
    Forsgren A; Striby AC
    Scand J Infect Dis; 1988; 20(5):531-4. PubMed ID: 3065926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New hemolysin (gamma) produced by Escherichia coli.
    Walton JR; Smith DH
    J Bacteriol; 1969 Apr; 98(1):304-5. PubMed ID: 4891808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a nalidixic-acid-resistant mutant of Escherichia coli as a strict aerobe.
    Yoshizawa Y; Yamamoto N
    Microbiol Immunol; 1989; 33(6):449-57. PubMed ID: 2549346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae.
    Ruiz J; Gómez J; Navia MM; Ribera A; Sierra JM; Marco F; Mensa J; Vila J
    Diagn Microbiol Infect Dis; 2002 Apr; 42(4):257-61. PubMed ID: 12007443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity.
    Yamagishi J; Furutani Y; Inoue S; Ohue T; Nakamura S; Shimizu M
    J Bacteriol; 1981 Nov; 148(2):450-8. PubMed ID: 6271730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive R plasmid mutator effect on chromosomal mutation to nalidixic acid resistance in nalidixic acid-exposed cultures of Escherichia coli.
    Ambler JE; Pinney RJ
    J Antimicrob Chemother; 1995 May; 35(5):603-9. PubMed ID: 7592173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nalidixic acid-induced protein alterations in Escherichia coli.
    Chao L
    Antimicrob Agents Chemother; 1977 Jan; 11(1):167-70. PubMed ID: 319748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli.
    Yamagishi J; Yoshida H; Yamayoshi M; Nakamura S
    Mol Gen Genet; 1986 Sep; 204(3):367-73. PubMed ID: 3020376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemolysin production in Escherichia coli associated with nalidixic acid resistance.
    Walton JR; Smith DH
    Antimicrob Agents Chemother (Bethesda); 1968; 8():54-6. PubMed ID: 4898540
    [No Abstract]   [Full Text] [Related]  

  • 32. Types of spontaneous nalidixic acid resistant mutants of Escherichia coli.
    Kumar S
    Indian J Exp Biol; 1980 Apr; 18(4):341-3. PubMed ID: 6995285
    [No Abstract]   [Full Text] [Related]  

  • 33. The problems of drug-resistant pathogenic bacteria. In vitro and in vivo methodology for detecting and evaluating inhibitors of transfer of resistance factors.
    Ott JL; Short LJ; Holmes DH
    Ann N Y Acad Sci; 1971 Jun; 182():312-21. PubMed ID: 4936667
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro emergence of Escherichia coli and Pseudomonas aeruginosa strains resistant to norfloxacin and nalidixic acid.
    Piffaretti JC; Demarta A; Leidi-Bulla L; Peduzzi R
    Eur J Clin Microbiol; 1983 Dec; 2(6):600-1. PubMed ID: 6230227
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of R-factor plasmids on host-cell responses to nalidixic acid I. Increased susceptibility of nalidixic acid-sensitive hosts.
    Crumplin GC; Smith JT
    J Antimicrob Chemother; 1981 Apr; 7(4):379-88. PubMed ID: 7019186
    [No Abstract]   [Full Text] [Related]  

  • 36. The sensitivity of suppressed and unsuppressed lon strains of Escherichia coli to chemical agents which induce filamentation.
    James R; Gillies NE
    J Gen Microbiol; 1973 Jun; 76(2):429-36. PubMed ID: 4579133
    [No Abstract]   [Full Text] [Related]  

  • 37. Synchronous reinitiation of chromosome replication in E. coli B-r after nalidixic acid treatment.
    Ward CB; Hane MW; Glaser DA
    Proc Natl Acad Sci U S A; 1970 Jun; 66(2):365-9. PubMed ID: 4915886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid.
    Moniot-Ville N; Guibert J; Moreau N; Acar JF; Collatz E; Gutmann L
    Antimicrob Agents Chemother; 1991 Mar; 35(3):519-23. PubMed ID: 2039202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antimicrobial action of nalidixic acid and the effect on the elimination of resident drug-resistant Shigella and E. coli in mice].
    Ogasawara K; Ata S; Kasuya M; Kobayashi T
    Igaku To Seibutsugaku; 1965 Jun; 70(6):343-8. PubMed ID: 5318841
    [No Abstract]   [Full Text] [Related]  

  • 40. Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids.
    Greenwood D
    Antimicrob Agents Chemother; 1978 Mar; 13(3):479-83. PubMed ID: 400825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.